Tetracycline-class Drug class drugs

7 results

  • Amzeeq

    (Minocycline)
    Journey Medical Corporation
    Usage: AMZEEQ is indicated for the topical treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients aged 9 and older. It is not intended for treating infections and should be used to prevent drug-resistant bacteria development.

  • Doryx

    (doxycycline hyclate)
    Mayne Pharma Commercial LLC
    Usage: DORYX is indicated for treating rickettsial infections, sexually transmitted infections (e.g., chlamydia, gonorrhea), respiratory and specific bacterial infections, ophthalmic infections, and anthrax (post-exposure). It serves as an alternative treatment when penicillin is contraindicated and is also used for adjunctive therapy in severe acne and malaria prophylaxis.

  • Oracea

    (DOXYCYCLINE)
    Galderma Laboratories, L.P.
    Usage: ORACEA is indicated for treating inflammatory lesions of rosacea (papules and pustules) in adults but is not effective for generalized redness. It is not approved for treating infections or bacterial prophylaxis and has not been evaluated for other rosacea symptoms like erythema or ocular components.

  • Seysara

    (sarecycline hydrochloride)
    Almirall, LLC
    Usage: SEYSARA (sarecycline) is indicated for treating inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients aged 9 and older. Efficacy beyond 12 weeks and safety beyond 12 months are not established, and it is not evaluated for infections. Use as indicated to prevent drug resistance.

  • Targadox

    (doxycycline hyclate)
    Journey Medical Corporation
    Usage: TARGADOX® (doxycycline) is indicated for treating infections caused by susceptible bacteria, including certain rickettsial diseases, respiratory infections, and Chlamydia infections. It is also used for prophylaxis against malaria in short-term travelers. The drug should be used to prevent antibiotic resistance.

  • Ximino

    (minocycline hydrochloride)
    Journey Medical Corporation
    Usage: Ximino is indicated for treating inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients aged 12 and older. Its use should be limited to avoid drug-resistant bacteria, and it has not been shown effective for non-inflammatory lesions or for infections. Safety beyond 12 weeks is not established.

  • Zilxi

    (Minocycline)
    Journey Medical Corporation
    Usage: ZILXI is indicated for treating inflammatory lesions of rosacea in adults. It has not been evaluated for infection treatment and should be used as directed to prevent drug-resistant bacteria and maintain the effectiveness of other antibacterial drugs.